Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Parks

Showing results (21-30 of 627) with videos related to

Pageof 63
Sort By:
Current Atherosclerosis Reports|October 17, 2001
Recent findings in the study of postprandial lipemiaE J Parks
Health Physics|February 1, 1979
A more sensitive method for the assay of 222Rn concentrations in water samples with liquid scintillation countersN J Parks
Journal of the National Medical Association|October 5, 2010
A Plea for Suggestive TherapyW J Parks
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 9, 2004
Adenovirus protein IX: a new look at an old proteinRobin J Parks
Clinical Genetics|August 17, 2000
Improvements in adenoviral vector technology: overcoming barriers for gene therapyR J Parks
Surgery|September 1, 1973
Postoperative peripheral neuropathiesB J Parks
Personality & Social Psychology Bulletin|March 9, 2013
Exclusion as self-protection: the function of subtypes for ingroup membersElizabeth J Parks-Stamm
Integrated Healthcare Report|November 3, 1996
Reassessing the value of vertical integrationR Nash, J Parks
Current Gene Therapy|July 12, 2002
Separating fact from fiction: assessing the potential of modified adenovirus vectors for use in human gene therapyAndrea Amalfitano, Robin J Parks
Journal of Virology|April 5, 2019
Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Suppresses Human Adenovirus Gene Expression and ReplicationBratati Saha, Robin J Parks
Pageof 63

Showing results (21-30 of 627) with videos related to

Sort By:
Pageof 63
Current Atherosclerosis Reports|October 17, 2001
Recent findings in the study of postprandial lipemiaE J Parks
Health Physics|February 1, 1979
A more sensitive method for the assay of 222Rn concentrations in water samples with liquid scintillation countersN J Parks
Journal of the National Medical Association|October 5, 2010
A Plea for Suggestive TherapyW J Parks
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 9, 2004
Adenovirus protein IX: a new look at an old proteinRobin J Parks
Clinical Genetics|August 17, 2000
Improvements in adenoviral vector technology: overcoming barriers for gene therapyR J Parks
Surgery|September 1, 1973
Postoperative peripheral neuropathiesB J Parks
Personality & Social Psychology Bulletin|March 9, 2013
Exclusion as self-protection: the function of subtypes for ingroup membersElizabeth J Parks-Stamm
Integrated Healthcare Report|November 3, 1996
Reassessing the value of vertical integrationR Nash, J Parks
Current Gene Therapy|July 12, 2002
Separating fact from fiction: assessing the potential of modified adenovirus vectors for use in human gene therapyAndrea Amalfitano, Robin J Parks
Journal of Virology|April 5, 2019
Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Suppresses Human Adenovirus Gene Expression and ReplicationBratati Saha, Robin J Parks
Pageof 63